FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113449616> ?p ?o ?g. }

• W2113449616 endingPage "518" @default.
• W2113449616 startingPage "510" @default.
• W2113449616 abstract "To profile plasma antibodies of patients with bipolar disorder (BD), an E. coli proteome microarray comprising ca. 4200 proteins was used to analyze antibody differences between BD patients and mentally healthy controls (HCs). The plasmas of HCs and patients aged 18–45 years with bipolar I disorder (DSM-IV) in acute mania (BD-A) along with remission (BD-R) were collected. The initial samples consisting of 19 BD-A, 20 BD-R, and 20 HCs were probed with the microarrays. After selecting protein hits that recognized the antibody differences between BD and HC, the proteins were purified to construct BD focus arrays for training diagnosis committees and validation. Additional six BD-A, six BD-R, six HCs, and nine schizophrenic disorder (SZ, as another psychiatric control) samples were individually probed with the BD focus arrays. The trained diagnosis committee in BD-A versus HC combined top six proteins, including rpoA, thrA, flhB, yfcI, ycdU, and ydjL. However, the optimized committees in BD-R versus HC and BD-A versus BD-R were of low accuracy (< 0.6). In the single blind test using another four BD-A, four HC, and four SZ samples, the committee of BD-A versus HC was able to classify BD-A versus HC and SZ with 75% sensitivity and 80% specificity that both HC and SZ were regarded as negative controls. The consensus motif of the six proteins, which form the committee of BD-A versus HC, is [KE]DIL[AG]L[LV]I[NL][IC][SVKH]G[LV][VN][LV] by Gapped Local Alignment of Motifs. We demonstrated that the E. coli proteome microarray is capable of screening BD plasma antibody differences and the selected proteins committee was successfully used for BD diagnosis with 79% accuracy. To profile plasma antibodies of patients with bipolar disorder (BD), an E. coli proteome microarray comprising ca. 4200 proteins was used to analyze antibody differences between BD patients and mentally healthy controls (HCs). The plasmas of HCs and patients aged 18–45 years with bipolar I disorder (DSM-IV) in acute mania (BD-A) along with remission (BD-R) were collected. The initial samples consisting of 19 BD-A, 20 BD-R, and 20 HCs were probed with the microarrays. After selecting protein hits that recognized the antibody differences between BD and HC, the proteins were purified to construct BD focus arrays for training diagnosis committees and validation. Additional six BD-A, six BD-R, six HCs, and nine schizophrenic disorder (SZ, as another psychiatric control) samples were individually probed with the BD focus arrays. The trained diagnosis committee in BD-A versus HC combined top six proteins, including rpoA, thrA, flhB, yfcI, ycdU, and ydjL. However, the optimized committees in BD-R versus HC and BD-A versus BD-R were of low accuracy (< 0.6). In the single blind test using another four BD-A, four HC, and four SZ samples, the committee of BD-A versus HC was able to classify BD-A versus HC and SZ with 75% sensitivity and 80% specificity that both HC and SZ were regarded as negative controls. The consensus motif of the six proteins, which form the committee of BD-A versus HC, is [KE]DIL[AG]L[LV]I[NL][IC][SVKH]G[LV][VN][LV] by Gapped Local Alignment of Motifs. We demonstrated that the E. coli proteome microarray is capable of screening BD plasma antibody differences and the selected proteins committee was successfully used for BD diagnosis with 79% accuracy. The etiology and genetic contributions of bipolar disorder (BD) 1The abbreviations used are:BDbipolar disarderBD-AmanicHChealthy controlTBSTtris buffered saline with tweenBSAbovine serum albuminBD-Rremission. 1The abbreviations used are:BDbipolar disarderBD-AmanicHChealthy controlTBSTtris buffered saline with tweenBSAbovine serum albuminBD-Rremission. largely remain unknown (1Phillips M.L. Frank E. Redefining bipolar disorder: toward DSM-V.Am. J. Psychiat. 2006; 163: 1135-1136Crossref PubMed Scopus (0) Google Scholar). Because of the presumed high level of etiologic heterogeneity and the overlap of dimensions across mood disorders and schizophrenia (2Craddock N. O'Donovan M.C. Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis.J. Med. Genet. 2005; 42: 193-204Crossref PubMed Scopus (469) Google Scholar), the main difficulty in making an exact diagnosis for psychiatric disorder is the lack of pathological biochemical index (3Phillips M.L. Kupfer D.J. Bipolar disorder diagnosis: challenges and future directions.Lancet. 2013; 381: 1663-1671Abstract Full Text Full Text PDF PubMed Scopus (376) Google Scholar). However, several lines of evidence support that various immunomodulatory factors, such as cytokine and soluble cytokine receptor, play an integral role in the pathophysiology of bipolar disorder (4Kapczinski F. Dal-Pizzol F. Teixeira A.L. Magalhaes P.V.S. Kauer-Sant'Anna M. Klamt F. Moreira J.C.F. Pasquali M.A.D. Fries G.R. Quevedo J. Gama C.S. Post R. Peripheral biomarkers and illness activity in bipolar disorder.J. Psychiatr. Res. 2011; 45: 156-161Crossref PubMed Scopus (196) Google Scholar, 5Tsai S.Y. Chen K.P. Yang Y.Y. Chen C.C. Lee J.C. Singh V.K. Leu S.J.C. Activation of indices of cell-mediated immunity in bipolar mania.Biol. Psychiatry. 1999; 45: 989-994Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar, 6Goldstein B.I. Kemp D.E. Soczynska J.K. McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.J. Clin. Psychiatry. 2009; 70: 1078-1090Crossref PubMed Scopus (435) Google Scholar, 7Kronfol Z. Remick D.G. Cytokines and the brain: implications for clinical psychiatry.Am. J. Psychiat. 2000; 157: 683-694Crossref PubMed Scopus (646) Google Scholar). For example, several studies have reported that cell-mediated immunity cytokine abundance is correlated with mood state (8Brietzke E. Kauer-Sant'Anna M. Teixeira A.L. Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder.Brain Behav. Immun. 2009; 23: 1079-1082Crossref PubMed Scopus (114) Google Scholar, 9Brietzke E. Stertz L. Fernandes B.S. Kauer-Sant'Anna M. Mascarenhas M. Vargas A.E. Chies J.A. Kapczinski F. Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder.J. Affect. Disord. 2009; 116: 214-217Crossref PubMed Scopus (344) Google Scholar). Our early works also found that higher levels of soluble interleukin-2 receptor (sIL-2R) (5Tsai S.Y. Chen K.P. Yang Y.Y. Chen C.C. Lee J.C. Singh V.K. Leu S.J.C. Activation of indices of cell-mediated immunity in bipolar mania.Biol. Psychiatry. 1999; 45: 989-994Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar, 10Tsai S.Y. Yang Y.Y. Kuo C.J. Chen C.C. Leu S.J. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.J. Affect. Disord. 2001; 64: 185-193Crossref PubMed Scopus (90) Google Scholar) and interleukin 1 receptor antagonist (IL-1Ra) (5Tsai S.Y. Chen K.P. Yang Y.Y. Chen C.C. Lee J.C. Singh V.K. Leu S.J.C. Activation of indices of cell-mediated immunity in bipolar mania.Biol. Psychiatry. 1999; 45: 989-994Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar, 11Tsai S.Y. Chung K.H. Wu J.Y. Kuo C.J. Lee H.C. Huang S.H. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.J. Affect. Disord. 2012; 136: 110-116Crossref PubMed Scopus (90) Google Scholar) are accompanied with bipolar mania. Furthermore, the abnormalities of total immunoglobulins levels in body fluid are observed in BD patients (12Hamdani N. Doukhan R. Kurtlucan O. Tamouza R. Leboyer M. Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.Curr. Psychiat. Rep. 2013; 15: 1-8Crossref Scopus (73) Google Scholar, 13Yolken R.H. Torrey E.F. Viruses, schizophrenia, and bipolar disorder.Clin. Microbiol. Rev. 1995; 8: 131-145Crossref PubMed Google Scholar). bipolar disarder manic healthy control tris buffered saline with tween bovine serum albumin remission. bipolar disarder manic healthy control tris buffered saline with tween bovine serum albumin remission. The possibility of biomarkers for assisting BD diagnosis has been recently highlighted (14Singh I. Rose N. Biomarkers in psychiatry.Nature. 2009; 460: 202-207Crossref PubMed Scopus (248) Google Scholar, 15Kapczinski F. Dias V.V. Kauer-Sant'Anna M. Brietzke E. Vazquez G.H. Vieta E. Berk M. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009; 33: 1366-1371Crossref PubMed Scopus (139) Google Scholar, 16Alawieh A. Zaraket F.A. Li J.L. Mondello S. Nokkari A. Razafsha M. Fadlallah B. Boustany R.M. Kobeissy F.H. Systems biology, bioinformatics, and biomarkers in neuropsychiatry.Front. Neurosci. 2012; 6: 187Crossref PubMed Google Scholar). Tumor necrosis factor alpha (TNF-α), 3-nytrotrosine, interleukin-6, interleukin-10, and brain-derived neurotrophic factor in body fluids are potentially useful for classifying stages of BD (15Kapczinski F. Dias V.V. Kauer-Sant'Anna M. Brietzke E. Vazquez G.H. Vieta E. Berk M. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009; 33: 1366-1371Crossref PubMed Scopus (139) Google Scholar). Nevertheless, they are not specific for distinguishing from other psychiatric diseases (17Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Psychiatry Clin. Neurosci. 2010; 64: 341-357Crossref PubMed Scopus (320) Google Scholar). Chronic inflammation exists in medicated bipolar patients displaying varied correlations with leptin, insulin, soluble TNF receptor-1 (sTNF-R1), and IL-1Ra (11Tsai S.Y. Chung K.H. Wu J.Y. Kuo C.J. Lee H.C. Huang S.H. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.J. Affect. Disord. 2012; 136: 110-116Crossref PubMed Scopus (90) Google Scholar). Notwithstanding, controversy exists as to whether these phenomena are state-dependent (5Tsai S.Y. Chen K.P. Yang Y.Y. Chen C.C. Lee J.C. Singh V.K. Leu S.J.C. Activation of indices of cell-mediated immunity in bipolar mania.Biol. Psychiatry. 1999; 45: 989-994Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar), normalize in remission (18Knijff E.M. Breunis M.N. Kupka R.W. de Wit H.J. Ruwhof C. Akkerhuis G.W. Nolen W.A. Drexhage H.A. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment.Bipolar Disord. 2007; 9: 743-753Crossref PubMed Scopus (129) Google Scholar), or represent trait markers exacerbated by the affective episodes (19Breunis M.N. Kupka R.W. Nolen W.A. Suppes T. Denicoff K.D. Leverich G.S. Post R.M. Drexhage H.A. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder.Biol. Psychiatry. 2003; 53: 157-165Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar). These discrepancies may be explained by heterogeneity in mood state, methodological differences, and not controlling for known confounds, such as obesity (6Goldstein B.I. Kemp D.E. Soczynska J.K. McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.J. Clin. Psychiatry. 2009; 70: 1078-1090Crossref PubMed Scopus (435) Google Scholar). In addition to inflammatory markers, increasing production of antibodies (20Hart D.J. Heath R.G. Sautter Jr., F.J. Schwartz B.D. Garry R.F. Choi B. Beilke M.A. Hart L.K. Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder.Biol. Psychiatry. 1999; 45: 704-714Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 21Dickerson F.B. Boronow J.J. Stallings C. Origoni A.E. Cole S. Krivogorsky B. Yolken R.H. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.Biol. Psychiatry. 2004; 55: 588-593Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar, 22Gerber S.I. Krienke U.J. Biedermann N.C. Grunze H. Yolken R.H. Dittmann S. Langosch J.M. Impaired functioning in euthymic patients with bipolar disorder - HSV-1 as a predictor.Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012; 36: 110-116Crossref PubMed Scopus (23) Google Scholar) and immunoglobulins (23Legros S. Mendlewicz J. Wybran J. Immunoglobulins, autoantibodies, and other serum protein fractions in psychiatric disorders.Eur. Arch. Psychiatry Neurol. Sci. 1985; 235: 9-11Crossref PubMed Scopus (51) Google Scholar, 24Wadee A.A. Kuschke R.H. Wood L.A. Berk M. Ichim L. Maes M. Serological observations in patients suffering from acute manic episodes.Hum. Psychopharmacol. 2002; 17: 175-179Crossref PubMed Scopus (101) Google Scholar) may be implicated with BD. In recent years, proteomic technologies based on mass spectrometry have been increasingly used, especially in the search for diagnostic and prognostic biomarkers in neuropsychiatric disorders (25Sokolowska I. Ngounou Wetie A.G. Wormwood K. Thome J. Darie C.C. Woods A.G. The potential of biomarkers in psychiatry: focus on proteomics.J. Neural. Transm. 2013; (submitted)PubMed Google Scholar). Protein microarrays have been demonstrated as an effective high throughput platform for analysis of aberrant immune responses in diseases (26Chen C.S. Zhu H. Protein microarrays.Biotechniques. 2006; 40: 423-429Crossref PubMed Scopus (68) Google Scholar, 27Tao S.C. Chen C.S. Zhu H. Applications of protein microarray technology.Comb. Chem. High T. Scr. 2007; 10: 706-718Crossref PubMed Scopus (67) Google Scholar, 28Wilson D.S. Nock S. Recent developments in protein microarray technology.Angew Chem. Int. Edit. 2003; 42: 494-500Crossref PubMed Scopus (270) Google Scholar, 29Caiazzo R.J. Maher A.J. Drummond M.P. Lander C.I. Tassinari O.W. Nelson B.P. Liu B.C.S. Protein microarrays as an application for disease biomarkers.Proteom. Clin. Appl. 2009; 3: 138-147Crossref PubMed Scopus (24) Google Scholar). It is hypothesized that the trait or state-dependent biomarkers of bipolar disorder may exist. We attempted to identify a committee of proteins for the diagnosis of BD through employing the ca. 4200 E. coli proteins in a microarray format. The two-phase strategy for identification and validation protein hits (30Song Q. Liu G. Hu S. Zhang Y. Tao Y. Han Y. Zeng H. Huang W. Li F. Chen P. Zhu J. Hu C. Zhang S. Li Y. Zhu H. Wu L. Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology.J. Proteome Res. 2010; 9: 30-39Crossref PubMed Scopus (62) Google Scholar) was used in this study. Although the antigens on the microarray may not be directly associated with BD, this microarray provided hundreds of thousands of epitopes for analyzing antibody profiles of plasma samples in a high throughput fashion. All the patients were recruited from the Department of Psychiatry, Taipei Medical University Hospital in Taiwan. Acute in-patients were invited to participate in the study on the basis of the inclusion criteria: (1) fulfilling the DSM-IV criteria for bipolar I, manic (BD-A) at index evaluation; (2) 18 to 45 years old; and (3) physically healthy condition. The diagnosis was established by two experienced psychiatrists using the structured interview schedule. Age- and gender-matched healthy controls (HCs) were recruited and screened for a history of any DSM-IV Axis I disorder using a well-validated Chinese version of the General Health Questionnaire (31Cheng T.A. Williams P. The design and development of a screening questionnaire (CHQ) for use in community studies of mental disorders in Taiwan.Psychol. Med. 1986; 16: 415-422Crossref PubMed Scopus (263) Google Scholar). Exclusion criteria for both groups were the presence of any type of Axis I disorder, a history of autoimmune or any endocrine disease, a current infection or allergy, or the use of any medication possibly affecting cytokines, blood lipids, or endocrine levels. Acute manic episode was defined as patients currently fulfilling criteria for a manic episode along with >26 scores on the Young Mania Rating Scale (32Young R.C. Biggs J.T. Ziegler V.E. Meyer D.A. A rating scale for mania: reliability, validity, and sensitivity.Br. J. Psychiatry. 1978; 133: 429-435Crossref PubMed Scopus (6574) Google Scholar). Physically healthy schizophrenic (SZ) patients (DSM-IV) aged 18 to 45 years were recruited as a comparison group. After an overnight fast beginning at 24:00 h, BD-A patients and control subjects provided blood samples between 08:30 h and 09:30 h in the following morning. Follow-up blood samples of the same manic patients in remission (BD-R) were collected, that is, when they had Young Mania Rating Scale scores of <5 and Hamilton Depression Rating Scale-21 scores of <7 (33Strakowski S.M. Tsai S.Y. Delbello M.P. Chen C.C. Fleck D.E. Adler C.M. Arndt S. Amicone J. Outcome following a first manic episode: cross-national US and Taiwan comparison.Bipolar Disord. 2007; 9: 820-827Crossref PubMed Scopus (28) Google Scholar). Heparinized blood was drawn by venous puncture. Plasma was collected and frozen at −80 °C until used. The study is registered at http://dcwrdsys.tmu.edu.tw/tmujirb/(NO. 201201014). The high throughput protein expression, protein purification, and protein printing were modified from our previous study (34Chen C.S. Korobkova E. Chen H. Zhu J. Jian X. Tao S.C. He C. Zhu H. A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli.Nat. Methods. 2008; 5: 69-74Crossref PubMed Scopus (101) Google Scholar). To print the proteome microarray, all purified protein were spotted in duplicate on each aldehyde slide by SmartArrayer 136 (CapitalBio, Beijing, China) at 4 °C. After printing proteins, the proteome microarray chips were kept at 4 °C for protein immobilization on the slides for 8 h. In the end, the chips were stored at −80 °C before probing with samples. The proteome chip was thawed using tris buffered saline with tween 20 (TBST) and blocked with 3% bovine serum albumin (BSA) in tris buffered saline (TBS) for 1 h at ambient temperature. After removing the blocking solution, 3 ml of diluted plasma sample with 1:100 dilution in 1% w/v BSA in TBST was added on the chip and incubated at 4 °C for overnight. Then, the chip was washed with 100 ml of TBST for 10 min. After removing the washing solution, 3 ml of 60 ng/ml Cy3-conjugated rabbit anti-human IgA+IgG+IgM antibodies in 1% w/v BSA of TBST was introduced to the chip for 1 h incubation at room temperature for secondary antibody hybridization. The slide was washed by CapitalBio SlideWasherTM using TBST two times for 5 min and DI water once for 10 s and then dried by centrifugation. Finally, the chip was read using CapitalBio LuxScanTM scanner with an excitation wavelength of 532 nm and emission wavelength of 570 nm. The chip images were analyzed by GenePix 6.0. The data were pretreated by the following procedures. First, signal intensities were normalized by robust-linear-model (RLM) (35Sboner A. Karpikov A. Chen G. Smith M. Mattoon D. Freeman-Cook L. Schweitzer B. Gerstein M.B. Robust-linear-model normalization to reduce technical variability in functional protein microarrays.J. Proteome Res. 2009; 8: 5451-5464Crossref PubMed Scopus (51) Google Scholar). Second, signal intensities below 256 were replaced as the minimum values of 256. Third, principle component analysis strategy was used to screen out bad chips (36Hoff P. Modern applied statistics with S-PLUS.Sociol. Method Res. 2001; 30: 293-295Crossref Google Scholar). Linear Models for Microarray Data (Limma) was used for statistical analysis with the R package (37Kooperberg C. Aragaki A. Strand A.D. Olson J.M. Significance testing for small microarray experiments.Stat. Med. 2005; 24: 2281-2298Crossref PubMed Scopus (48) Google Scholar, 38Kendziorski C. Irizarry R.A. Chen K.S. Haag J.D. Gould M.N. On the utility of pooling biological samples in microarray experiments.Proc. Natl. Acad. Sci. U.S.A. 2005; 102: 4252-4257Crossref PubMed Scopus (414) Google Scholar). Finally, the protein hits were examined by eyeballing with the original images. The rule of eyeballing was based on the comparison of the intensity of the interest spot with neighboring spots. Protein chip analysis tool (ProCAT) was used for normalization with Perl 5.0 (39Zhu X. Gerstein M. Snyder M. ProCAT: a data analysis approach for protein microarrays.Genome Biol. 2006; 7: R110Crossref PubMed Google Scholar). The local cut-off was set as the mean plus three standard deviations. The binomial test was used to select hits between sample groups. The p value lower than 0.05 was considered as specific hit for each group. The resultant hits list was checked by eyeballing with the original images. The selected 48 protein hits (Table I) were purified and printed on the slide for the fabrication of the BD focus array using the same protocol for the fabrication of the entire E. coli proteome array. The format of the focus array was designed for a 4 × 24-well cassette. The pitch of spot to spot was 350 μm. Each protein was printed in triplicate by SmartArrayer 136 (CapitalBio) at 4 °C. After printing proteins, the chips were kept at 4 °C for protein immobilization on the slides for 8 h. The resultant chips were stored at −80 °C before carrying out experiments.Table IBipolar disorder protein hits identified by E. coli K12 proteome chipsPair groupHigher-expressed hitsLower-expressed hitsBD-A vs. HCyiaFthrAycdNyaiXychMrpoAybjQycfKstfRygcOglpTyebTybiHynaIyjgTyigTycdUyjcOydjLflgFfldAyecFcheWpurFglcFyfcIyhbZlysUrfaCybbJflhByihIrfaEnarGyqhDyeiQBD-R vs. HClpxAyqjGyiaFuupyciQamyAlacZmalYBD-A vs. BD-RflgJybbJyjbCphbAynjAdppA Open table in a new tab The focus array was thawed using TBST (pH 7.4) and blocked with 3% w/v BSA of TBS (pH 7.4) for 1 h at ambient temperature. After removing the blocking solution, the chips were assembled by 4 × 24-well hybridization cassette (Arrayit®). Each 200 μl of plasma sample with 1:100 dilution in 1% w/v BSA of TBST (pH 7.4) was added into the individual well and incubated at ambient temperature for 1 h. One percent w/v BSA was used as negative control. Then, the chips were rinsed with 100 ml of TBST (pH 7.4) for 10 min. After removing the rinsing solution, 3 ml of 60 ng/ml Cy3-conjugated rabbit anti-human IgA+IgG+IgM antibodies in 1% w/v BSA was introduced to the chip and incubated for 1 h at room temperature. The slide was washed and dried by centrifugation with CapitalBio SlideWasherTM. The resultant chip was read using CapitalBio LuxScanTM scanner with an excitation wavelength of 532 nm and emission wavelength of 570 nm. The Cluster 3.0 (40de Hoon M.J. Imoto S. Nolan J. Miyano S. Open source clustering software.Bioinformatics. 2004; 20: 1453-1454Crossref PubMed Scopus (2336) Google Scholar) was used to display heat map. The data was presented by ratio of hit foreground to background signal intensity. The correlation algorithm in Cluster 3.0 was used for classifying protein hits and samples in hierarchy. The Java TreeView was used to output the image of heat map. Additional plasma-collection of six BD-A, six BD-R, six SZ patients, and six HCs, were probed with the BD focus arrays. The best combination of proteins for diagnosis was decided according to the accuracy of each combination in each group. The trained cluster databases were used for the following single blind tests. Another sample collection of four BD-A, four HC, and six SZ were used and assigned randomly with X01 to X14 in the single blind tests that the experimenter did not know the sample X information and the results were compared with the real sample information provided by diagnosis of psychiatrists. The BD-A committee, including the combination of rpoA, thrA, flhB, yfcI, ycdU, and ydjL, was used to classify sample X01 to X14 with focus arrays and trained cluster databases. The result of sample X in each pair group of BD-A versus HC, BD-A versus SZ, and HC versus SZ, had the same weight for committee voting. The sample X was predicted by the majority of votes. The sensitivity was calculated using number of true positive divided by sum of number of true positive and number of false negative. The specificity was calculated using the number of true negatives divided by sum of the number of true negatives and the number of false positives. The accuracy was calculated using the sum of number of true positives and number of true negatives divided by sum of the number of positives and negatives. All six BD-A protein committees, including rpoA, thrA, flhB, yfcI, ycdU, and ydjL were converted to FASTA format and analyzed by Gapped Local Alignment of Motifs (GLAM2) for surveying consensus motif (41Frith M.C. Saunders N.F. Kobe B. Bailey T.L. Discovering sequence motifs with arbitrary insertions and deletions.PLoS Comput. Biol. 2008; 4: e1000071Crossref PubMed Scopus (235) Google Scholar). The parameters of GLAM2 were set as default. The resultant motif was then searched in entire E. coli K12 proteome by GLAM2SCAN with hypergeometric probability distribution test. Twenty BD patients participated in the study, but one merely agreed to provide his blood sample in his remission phase. A total of 59 plasma samples included 19 in acute mania (BD-A), 20 in remission (BD-R), and 20 healthy controls (HCs). We probed each plasma sample with the E. coli proteome chip. Fig. 1A illustrates the chip assays. Fig. 1B shows the representative microarray image of the BD and HC, respectively. The microarray images of BD and HC samples show different antibody binding profiles. The representative thrA protein spots show higher signal intensity in HC than BD, and yiaF protein spots show lower signal intensity in HC than BD. This represents that BD plasma has both higher-expressed and lower-expressed antibodies compared with HC. The obtained images of BD-A, BD-R, and HC samples were further analyzed by bioinformatics. Using RLM and selection of protein hits by Limma under a stringent threshold (false discovery rate < 0.05 and log fold change > 1), we found 17, 11, and nine significant protein hits in each pair group of BD-A versus HC, BD-R versus HC, and BD-A versus BD-R. On the other hand, the normalized ProCAT data was analyzed by binomial test (p < 0.05), and we found 58, 56, and 13 hits in each pair group of BD-A versus HC, BD-R versus HC, and BD-A versus BD-R. To confirm the reliability of analyses, all hits were checked by eyeballing using the original image for removing false hits. The final list was shown in Table I. In BD-A versus HC, six higher-expressed hits and 30 lower-expressed hits were found. Higher-expressed hits in BD-A versus HC represented more antibodies binding in BD-A plasma samples compared with HC. Lower-expressed hits in BD-A versus HC represented less antibodies binding in BD-A plasma samples compared with HC. In BD-R versus HC, eight proteins (four higher-expressed and four lower-expressed hits) were obtained. In BD-A versus BD-R, only six lower-expressed hits were found. YiaF was both found in BD-A versus HC and BD-R versus HC; ybbJ was both found in BD-R versus HC and BD-A versus BD-R. Forty eight hit proteins were identified (Table I) and showed statistically different signal intensities between BD and HC. To overview the performance of individual hit and accuracy of combination hits in each pair group of BD-A versus HC, BD-R versus HC, and BD-A versus BD-R, Cluster 3.0(40de Hoon M.J. Imoto S. Nolan J. Miyano S. Open source clustering software.Bioinformatics. 2004; 20: 1453-1454Crossref PubMed Scopus (2336) Google Scholar) was used to display heat maps (Fig. 2). As shown in Fig. 2A, the pair groups of BD-A versus HC were clustered to two groups by using 36 protein hits in BD-A versus HC with an accuracy of 0.69, indicating these hits were able to classify BD-A and HC. In Fig. 2B, the pair groups of BD-R versus HC were not clearly classified by using the eight hits of BD-R versus HC (accuracy = 0.6). In Fig. 2C, the pair groups of BD-A versus BD-R were also not clustered using the six hits of BD-A versus BD-R (accuracy = 0.59). These results indicated the identified hits were not capable of distinguishing BD-R from either HC or BD-A. The E. coli protein hits including 36 hits of BD-A versus HC, eight hits of BD-R versus HC, and six hits of BD-A versus BD-R (Table I) were purified from the E. coli clones and printed in triplicate for the fabrication of BD focus arrays. Another plasma collection of six BD-A, six BD-R, six HC, and nine SZ were used in focus arrays for protein committee training. SZ samples were used as another psychiatry disease control to test the specificity. After conducting chip assays using BD focus arrays (Fig. 3A), most triplicate spots of hits showed highly reproducible signals. The negative control of 1% BSA in TBST and blank did not show any signal. In the results of focus arrays, an individual hit cannot classify samples with high accuracy (data not shown). To improve the classifying ability for BD, combinations of protein hits as diagnosis committees were trained and tested. The training and tuning strategy of the protein committee selection was based on ranking of each protein hit candidate in each pair group with individual accuracy from the results of the focus array. The combination of protein hits was optimized using the results based on clustering. As shown in Fig. 3B, combination of top six protein hits, including rpoA, thrA, flhB, yfcI, ycdU, and ydjL, classify BD-A and HC with an accuracy of 0.75. However, even after the committees of the BD-R versus HC and BD-A versus BD-R were optimized (Fig. 3C and D), the accuracy was still low (< 0.60). Therefore, the BD-R related hits were ruled out in the BD committee. We focused the BD-A committee on the following validation. The specificity of BD-A committee in SZ samples was examined (Fig. 3E), and the BD-A committee, from the results of BD-A versus HC, was also capable of classifying BD-A and SZ samples with an accuracy of 0.67. The SZ and HC samples were regarded as similar groups by the BD-A committee (Fig. 3F). The trained clusters of BD-A versus HC, BD-A versus SZ, and HC versus SZ (Fig. 3B, 3E, and 3F) were used as databases for classifying samples in the following single blind test. To test the performance of the diagnosis committee and avoid bias, single blind tests were conducted. Another plasma collection of four BD-A, four HC, and six SZ were randomly assigned as sample X01 to X14 and conducted in the single blind test. A tested sample X was voted according to the clustering results from the training databases (BD-A versus HC, BD-A versus SZ, and HC versus SZ). The result of each group had the same weight for the committee voting. For instance, in Fig. 4A, sample X01 was classified to BD-A; in Fig. 4B, sample X01 was classified to BD-A; in Fig. 4C, sample X01 was classified to SZ. Because the total results of sample X01 were two BD-A and one SZ, the prediction of sample X01 was BD-A according the majority of votes. After finishing the predictions of sample X01 to X14, the results were compared with the real sample information. In BD-A samples, three BD-A samples were diagnosed correctly (true positive) and one BD-A were misdiagnosed (false negative); in HC samples, all four HC samples were diagnosed correctly (true negative); in SZ samples, four SZ samples were diagnosed correctly (true negative) and two SZ samples were misdiagnosed (false positive). Therefore, the sensitivity of BD-A committee was 75% and the specificity of BD-A committee was 80%. The BD-A committee of rpoA, thrA, flhB, yfcI, ycdU, and ydjL was able to classify BD-A versus HC and SZ with an accuracy of 79% in the single blind test. To survey whether novel consensus motif existed among the six committee proteins, the Gapped Local Alignment of Motifs (GLAM2) was performed (41Frith M.C. Saunders N.F. Kobe B. Bailey T.L. Discovering sequence motifs with arbitrary insertions and deletions.PLoS Comput. Biol. 2008; 4: e1000071Crossref PubMed Scopus (235) Google Scholar). The GLAM2 has been used in the random peptide microarray for exploring antibody recognition of amino acid sequence space (42Halperin R.F. Stafford P. Johnston S.A. Exploring antibody recognition of sequence space through random-sequence peptide microarrays.Mol. Cell. Proteomics. 2011; 10 (M110 000786)Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar). In this study, we found the consensus motif among the six proteins is [KE]DIL[AG]L[LV]I[NL][IC][SVKH]G[LV][VN][LV] (Fig. 5). Furthermore, we used this motif to search entire E. coli K12 proteome by GLAM2SCAN (Table II). The resultant top six ranking proteins containing this motif were indeed the coincided six proteins (p < 0.0001 by hypergeometric probability distribution test). It indicated this motif was statistically unique in the entire E. coli K12 proteome.Table IITop 10 proteins list of [KE]DIL[AG]L[LV]I[NL][IC][SVKH]G[LV][VN][LV] enriched in entire E. coli K12. The motif was searched in entire E. coli K12 proteome by GLAM2SCANRankNameAccession numberStartSiteEndScore1ydjLNP_416290244KDNLGLVIECSGANI25829.32flhBNP_41639487EAMLALLPLISGVVL10128.53thrANP_414543504ANSKALLTNVHGLNL51826.04rpoANP_41775476EDILEILLNLKGLAV9025.95ycdUNP_415548200KSIIALLILC.GVVL21325.86yfcINP_416808186RDLLGLVDQIVSLLV20023.67yfdCNP_416849130MSNVGLLIRLWGVVL14417.68emrDNP_418129362QGSLGLLMTLMGLLI37616.99wzcNP_416564431AIILGLMLSIVGVLL44516.710sppANP_41628054ASRGALLLDISGVIV6816.2 Open table in a new tab The major finding of the present study is that E. coli proteome microarray reveals antibody profiles of bipolar manic patients varying from mentally healthy individuals. No evidence shows E. coli could be relevant pathogen of BD until now. Therefore, the recognized proteins may not be the direct antigens causing the abnormal immune response in BD patients. After training protein hits committees and single blind tests, six hit proteins in bipolar mania can be considered as a committee to identify patients in acute mania. By using GLAM2, the conserved protein sequence is found in the bipolar mania committee. These results demonstrate that the E. coli proteome microarray is a promising platform for analyzing aberrant antibody related disease. The strengths of the E. coli proteome microarray are that they offer linear and conformational epitopes for systematic evolution of antibody–protein interactions and that antigen based microarrays allow screening in a high throughput and cost-effective manner (43Ramachandran N. Srivastava S. Labaer J. Applications of protein microarrays for biomarker discovery.Proteom. Clin. Appl. 2008; 2: 1444-1459Crossref PubMed Scopus (64) Google Scholar). The present results provide additional evidence that the E. coli proteome microarray is capable of being exploited as an epitope library for screening abnormal immune related diseases and has been demonstrated to identify serological biomarkers of inflammatory bowel disease in our previous study (44Chen C.S. Sullivan S. Anderson T. Tan A.C. Alex P.J. Brant S.R. Cuffari C. Bayless T.M. Talor M.V. Burek C.L. Wang H.A. Li R. Datta L.W. Wu Y.Q. Winslow R.L. Zhu H. Li X.H. Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.Mol. Cell. Proteomics. 2009; 8: 1765-1776Abstract Full Text Full Text PDF PubMed Scopus (53) Google Scholar). To the best of our knowledge, this is the first study to systematically investigate the immune signatures of patients with BD by means of proteome microarrays. Intriguingly, the lower-expressed proteins in acute mania and remission of bipolar patients compared with mentally healthy controls show reduced production of some specific immunoglobulins, such as IgA, IgG, or IgM, in bipolar patients. This is additional evidence to support the state-dependent pathophysiology of patients with bipolar disorder (6Goldstein B.I. Kemp D.E. Soczynska J.K. McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.J. Clin. Psychiatry. 2009; 70: 1078-1090Crossref PubMed Scopus (435) Google Scholar, 11Tsai S.Y. Chung K.H. Wu J.Y. Kuo C.J. Lee H.C. Huang S.H. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.J. Affect. Disord. 2012; 136: 110-116Crossref PubMed Scopus (90) Google Scholar). The possible biomarkers of mood disorder and schizophrenia in the literature, including neurotrophic factors, circulating immunological parameters, thyroid hormones, neuropeptides, and oxidative stress markers, are limited by their specificity to each disorder (45Hope S. Melle I. Aukrust P. Steen N.E. Birkenaes A.B. Lorentzen S. Agartz I. Ueland T. Andreassen O.A. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.Bipolar Disord. 2009; 11: 726-734Crossref PubMed Scopus (131) Google Scholar). Most schizophrenic patients in this study were not classified as BD sample by the BD-A committee on the focus array. In the single blind test using 14 samples, the accuracy reached 79%. Not all the schizophrenic patients had active positive symptoms and schizophrenia shares some inflammatory parameters with bipolar mania (46Bergink V. Gibney S.M. Drexhage H.A. Autoimmunity, inflammation, and psychosis: a search for peripheral markers.Biol. Psychiatry. 2014; 75: 324-331Abstract Full Text Full Text PDF PubMed Scopus (195) Google Scholar). Notwithstanding, our findings suggest that the diagnosis committee in this study had favorable power to distinguish bipolar mania from schizophrenia. Several methodological limitations in this study should be addressed. First, the bipolar patients took various medications throughout the study period. The effects of various psychopharmacological treatments from acute mania to remission may confound the production of immunoglobulin. Second, although we controlled for age and sex, we could not rule out the possibility that smoking, activity level, dietary habits, and obesity may have confounding effects on these results. Third, our results also suffer from small sample size and the lack of measurements in BD euthymic phase. It is a preliminary report and further validation in large scale need to be conducted for reinforcing the use of BD-A six proteins committee. As second generation antipsychotics are indicated for acute phase of bipolar disorder and schizophrenia, it is worthwhile to use the aforementioned BD-A six protein committee to classify larger samples of BD and SZ patients with the same medication from acute phase to remission in further studies." @default.
• W2113449616 created "2016-06-24" @default.
• W2113449616 creator A5001841761 @default.
• W2113449616 creator A5003703206 @default.
• W2113449616 creator A5005731316 @default.
• W2113449616 creator A5030224810 @default.
• W2113449616 creator A5032725011 @default.
• W2113449616 creator A5037416766 @default.
• W2113449616 creator A5038995062 @default.
• W2113449616 creator A5065915119 @default.
• W2113449616 creator A5076554017 @default.
• W2113449616 creator A5091799367 @default.
• W2113449616 date "2015-03-01" @default.
• W2113449616 modified "2023-09-30" @default.
• W2113449616 title "Antibody Profiling of Bipolar Disorder Using Escherichia coli Proteome Microarrays" @default.
• W2113449616 cites W1595053742 @default.
• W2113449616 cites W1659530875 @default.
• W2113449616 cites W1982804845 @default.
• W2113449616 cites W1999475925 @default.
• W2113449616 cites W2000171400 @default.
• W2113449616 cites W2007446279 @default.
• W2113449616 cites W2010842586 @default.
• W2113449616 cites W2013106702 @default.
• W2113449616 cites W2016260633 @default.
• W2113449616 cites W2020533233 @default.
• W2113449616 cites W2022452100 @default.
• W2113449616 cites W2031329056 @default.
• W2113449616 cites W2034894224 @default.
• W2113449616 cites W2040512326 @default.
• W2113449616 cites W2041388941 @default.
• W2113449616 cites W2045565319 @default.
• W2113449616 cites W2050085626 @default.
• W2113449616 cites W2050284387 @default.
• W2113449616 cites W2050584458 @default.
• W2113449616 cites W2053209033 @default.
• W2113449616 cites W2056780460 @default.
• W2113449616 cites W2058136479 @default.
• W2113449616 cites W2064138257 @default.
• W2113449616 cites W2077421446 @default.
• W2113449616 cites W2087256811 @default.
• W2113449616 cites W2093006402 @default.
• W2113449616 cites W2096853514 @default.
• W2113449616 cites W2103795727 @default.
• W2113449616 cites W2109581630 @default.
• W2113449616 cites W2119847204 @default.
• W2113449616 cites W2128322831 @default.
• W2113449616 cites W2128752057 @default.
• W2113449616 cites W2134144722 @default.
• W2113449616 cites W2144034070 @default.
• W2113449616 cites W2149960646 @default.
• W2113449616 cites W2150413247 @default.
• W2113449616 cites W2153562609 @default.
• W2113449616 cites W2153718589 @default.
• W2113449616 cites W2155367235 @default.
• W2113449616 cites W2158388057 @default.
• W2113449616 cites W2167659819 @default.
• W2113449616 cites W4250142241 @default.
• W2113449616 cites W4250384187 @default.
• W2113449616 cites W4250669016 @default.
• W2113449616 doi "https://doi.org/10.1074/mcp.m114.045930" @default.
• W2113449616 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4528255" @default.
• W2113449616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26232422" @default.
• W2113449616 hasPublicationYear "2015" @default.
• W2113449616 type Work @default.
• W2113449616 sameAs 2113449616 @default.
• W2113449616 citedByCount "10" @default.
• W2113449616 countsByYear W21134496162016 @default.
• W2113449616 countsByYear W21134496162018 @default.
• W2113449616 countsByYear W21134496162019 @default.
• W2113449616 countsByYear W21134496162020 @default.
• W2113449616 countsByYear W21134496162022 @default.
• W2113449616 countsByYear W21134496162023 @default.
• W2113449616 crossrefType "journal-article" @default.
• W2113449616 hasAuthorship W2113449616A5001841761 @default.
• W2113449616 hasAuthorship W2113449616A5003703206 @default.
• W2113449616 hasAuthorship W2113449616A5005731316 @default.
• W2113449616 hasAuthorship W2113449616A5030224810 @default.
• W2113449616 hasAuthorship W2113449616A5032725011 @default.
• W2113449616 hasAuthorship W2113449616A5037416766 @default.
• W2113449616 hasAuthorship W2113449616A5038995062 @default.
• W2113449616 hasAuthorship W2113449616A5065915119 @default.
• W2113449616 hasAuthorship W2113449616A5076554017 @default.
• W2113449616 hasAuthorship W2113449616A5091799367 @default.
• W2113449616 hasBestOaLocation W21134496161 @default.
• W2113449616 hasConcept C104317684 @default.
• W2113449616 hasConcept C104397665 @default.
• W2113449616 hasConcept C111919701 @default.
• W2113449616 hasConcept C150194340 @default.
• W2113449616 hasConcept C159654299 @default.
• W2113449616 hasConcept C171196145 @default.
• W2113449616 hasConcept C185592680 @default.
• W2113449616 hasConcept C187191949 @default.
• W2113449616 hasConcept C41008148 @default.
• W2113449616 hasConcept C54355233 @default.
• W2113449616 hasConcept C547475151 @default.
• W2113449616 hasConcept C60644358 @default.
• W2113449616 hasConcept C70721500 @default.
• W2113449616 hasConcept C86803240 @default.

• next